Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pennant GroupPNTG +0.56%88 3-1 Month Momentum % is 22.44% as of Aug. 06, 2026. GuruFocus rates PNTG with a GF Score™ of 88/100 and a GF Value™ of $35.12 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 671 Healthcare Providers & Services companies, Pennant Group ranks better than 86.44% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-08-06), Pennant Group's 3-1 Month Momentum % is 22.44%.
The industry rank for Pennant Group's 3-1 Month Momentum % or its related term are showing as below:
PNTG's 3-1 Month Momentum % is ranked better than 86.44% of 671
companies
in the Healthcare Providers & Services industry
Industry Median: -2.78
vs PNTG: 22.44
Pennant Group (NAS:PNTG) 3-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Pennant Group 3-1 Month Momentum % Related Terms
PNTG vs ARDT, HCSG, INNV: 3-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Pennant Group's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pennant Group 3-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pennant Group's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Pennant Group's 3-1 Month Momentum % falls into.
Pennant Group (NAS:PNTG) 3-1 Month Momentum % Calculation
3-1 Month Momentum % is calculated as following:
3-1 Month Momentum %
=
( Price 1-month ago
/
Price 3-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pennant Group (PNTG) has a 3-1 Month Momentum % of 22.44% as of Aug. 06, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Pennant Group and its competitors. According to the industry distribution chart, Pennant Group ranks #91 out of 671 companies in the Healthcare Providers & Services industry, placing it in the top 13.6%.
Is Pennant Group's 3-1 Month Momentum % too high?
Pennant Group's current 3-1 Month Momentum % is 22.44%. Based on the distribution chart, Pennant Group ranks #91 out of 671 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Pennant Group has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pennant Group's 3-1 Month Momentum % compare to ARDT and HCSG?
According to the Healthcare Providers & Services industry distribution chart, Pennant Group ranks #91 out of 671 companies for 3-1 Month Momentum %. This places Pennant Group in the top 14% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Healthcare Providers & Services company?
A good 3-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Pennant Group and its competitors. Pennant Group's current 3-1 Month Momentum % is 22.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pennant Group stock overvalued right now?
Based on GuruFocus' analysis, Pennant Group (PNTG) is currently considered Modestly Overvalued. The stock's GF Value™ is $35.12, compared to a current price of $38.84 — trading 10.6% above its estimated fair value. The current 3-1 Month Momentum % is 22.44%. Pennant Group's overall GF Score™ is 88/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Pennant Group (PNTG), the current 3-1 Month Momentum % is 22.44% as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pennant Group (PNTG) Overvalued in 2026?
Based on GuruFocus' analysis, Pennant Group stock appears to be overvalued.
The current stock price of $38.84 is trading 10.6% above its estimated GF Value™ of $35.12.
GuruFocus considers Pennant Group to be Modestly Overvalued.
Key valuation signals for PNTG:
3-1 Month Momentum %: 22.44%
GF Value™: $35.12 vs. price of $38.84 (10.6% above fair value)
No single metric tells the full story. See the PNTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
88GF Score
Get the complete analysis for PNTG
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PNTG has been successfully added to your 
